Echo Therapeutics (ECTE) Announces First Quarter 2013 Financial Results
5/10/2013 7:24:25 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
PHILADELPHIA, May 10, 2013 — /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31, 2013. Echo's Quarterly Report on Form 10-Q, as filed with the SEC, will be available by visiting the Investors section of Echo's website at www.echotx.com.
Help employers find you! Check out all the jobs and post your resume.
comments powered by